Latest News and Press Releases
Want to stay updated on the latest news?
-
TARRYTOWN, New York, May 15, 2024 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica, Inc. (the “Company” or “PaxMedica”) (OTC:PXMD), a biopharmaceutical company dedicated to advancing treatments for...
-
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "APT-1011 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This "APT-1011 Emerging Drug...
-
TARRYTOWN, N.Y., Nov. 02, 2023 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica, Inc. (Nasdaq: PXMD), a pioneering biopharmaceutical company focused on advancing treatments for neurologic disorders, has...
-
Dublin, June 26, 2023 (GLOBE NEWSWIRE) -- The "Cyber Security: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Cyber Security Market to Reach...
-
Dublin, April 11, 2023 (GLOBE NEWSWIRE) -- The "Global Log Management Market (2023-2028) by Component, Deployment, Organization Size, Industry, and Geography, Competitive Analysis, Impact of...
-
Dublin, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The "Advanced Persistent Threat Protection - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market...
-
Woburn, MA, Dec. 27, 2022 (GLOBE NEWSWIRE) -- Kaspersky researchers have discovered that the infamous Advanced Persistent Threat (APT) actor BlueNoroff recently added sophisticated new malware...
-
CAMBRIDGE, Mass., Dec. 14, 2022 (GLOBE NEWSWIRE) -- The APWG's new Phishing Activity Trends Report reveals that in the third quarter of 2022, APWG observed 1,270,883 total phishing attacks — the...
-
CAMBRIDGE, Mass., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Register now for the world's only conference dedicated exclusively to cybercrime-related research — now in its 17th year as a publishing...
-
CAMBRIDGE, Mass., Nov. 18, 2022 (GLOBE NEWSWIRE) -- The APWG Symposium on Electronic Crime Research (APWG eCrime) is proud to announce the accepted papers for its 2022 edition of the conference,...